Ozaslan E - Search Results

1

Endoscopic large balloon dilation after sphincterotomy: is perforation risk an alarming issue?

Ozaslan E. Ozaslan E. Dig Dis Sci. 2013 May;58(5):1438. doi: 10.1007/s10620-013-2615-z. Epub 2013 Mar 17. Dig Dis Sci. 2013. PMID: 23504351 No abstract available.

2

Comment to "Sixty- versus thirty-seconds papillary balloon dilation after sphincterotomy for the treatment of large bile duct stones: a randomized controlled trial".

Ozaslan E. Ozaslan E. Dig Liver Dis. 2013 Aug;45(8):700. doi: 10.1016/j.dld.2013.02.004. Epub 2013 Mar 13. Dig Liver Dis. 2013. PMID: 23490342 No abstract available.

3

The comparison of two different 5.5 fr sphincterotomes for selective cannulation of the common bile duct: a prospective, randomized study.

Ozaslan E, Purnak T, Efe C, Ozaslan NG, Cengiz M. Ozaslan E, et al. Among authors: ozaslan ng. Dig Dis Sci. 2014 Dec;59(12):3078-84. doi: 10.1007/s10620-014-3268-2. Epub 2014 Jul 5. Dig Dis Sci. 2014. PMID: 24996379 Clinical Trial.

4

Large-balloon dilation after sphincterotomy: anatomical and technical issues.

Ozaslan E. Ozaslan E. Gastrointest Endosc. 2011 Sep;74(3):723-4; author reply 725. doi: 10.1016/j.gie.2011.04.033. Gastrointest Endosc. 2011. PMID: 21872722 No abstract available.

5

Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis.

Purnak T, Efe C, Kav T, Wahlin S, Ozaslan E. Purnak T, et al. Among authors: ozaslan e. Dig Dis Sci. 2017 Oct;62(10):2900-2907. doi: 10.1007/s10620-017-4728-2. Epub 2017 Sep 4. Dig Dis Sci. 2017. PMID: 28871464

6

The impact of sphincterotome design on selective cannulation of the common bile duct.

Ozaslan E, Ozaslan NG, Purnak T, Ozkaya G. Ozaslan E, et al. Among authors: ozaslan ng. J Gastroenterol Hepatol. 2013 Sep;28(9):1573-7. doi: 10.1111/jgh.12210. J Gastroenterol Hepatol. 2013. PMID: 23560869

7

Autoimmune hepatitis in the postpartum period.

Efe C, Purnak T, Ozaslan E. Efe C, et al. Among authors: ozaslan e. Clin Res Hepatol Gastroenterol. 2012 Aug;36(4):391-3. doi: 10.1016/j.clinre.2012.02.006. Epub 2012 Apr 3. Clin Res Hepatol Gastroenterol. 2012. PMID: 22481086

8

Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.

Efe C, Taii HA, Ytting H, Aehling N, Bhanji RA, Hagström H, Purnak T, Muratori L, Werner M, Muratori P, Klintman D, Schiano TD, Montano-Loza AJ, Berg T, Larsen FS, Alkhouri N, Ozaslan E, Heneghan MA, Yoshida EM, Wahlin S. Efe C, et al. Among authors: ozaslan e. Dig Dis Sci. 2018 May;63(5):1348-1354. doi: 10.1007/s10620-018-5011-x. Epub 2018 Mar 22. Dig Dis Sci. 2018. PMID: 29569003

9

The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature.

Efe C, Ozaslan E, Nasiroglu N, Tunca H, Purnak T, Altiparmak E. Efe C, et al. Among authors: ozaslan e. Dig Dis Sci. 2010 Aug;55(8):2417-21. doi: 10.1007/s10620-009-0996-9. Epub 2009 Oct 14. Dig Dis Sci. 2010. PMID: 19826950 Review. No abstract available.

10

The significance of duodenal white spots.

Ozaslan E, Purnak T, Kayhan B. Ozaslan E, et al. J Dig Dis. 2010 Jun;11(3):192; author reply 193. doi: 10.1111/j.1751-2980.2010.00436.x. J Dig Dis. 2010. PMID: 20579224 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page